References
- Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) [updated 2015] Available from: http://www.ginasthma.org/Accessed June 16, 2016
- Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management and Prevention of COPD [updated 2017] Available from: http://www.goldcopd.orgAccessed September 8, 2017
- DolovichMBAhrensRCHessDRDevice selection and outcomes of aerosol therapy: evidence-based guidelines. American College of Chest Physicians/American College of Asthma, Allergy, and ImmunologyChest2005127133537115654001
- Dal NegroRWPoveroMAcceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patientsMultidiscip Respir Med201611726865979
- BjermerLThe importance of continuity in inhaler device choice for asthma and chronic obstructive pulmonary diseaseRespiration201488434635225195762
- MahlerDAWatermanLAGiffordAHPrevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhalerJ Aerosol Med Pulm Drug Deliv201326317417923025451
- PrimeDde BackerWHamiltonMEffect of disease severity in asthma and chronic obstructive pulmonary disease on inhaler-specific inhalation profiles through the ELLIPTA® dry powder inhalerJ Aerosol Med Pulm Drug Deliv201528648649726372467
- LaubeBLJanssensHMde JonghFHCWhat the pulmonary specialist should know about the new inhalation therapiesEur Respir J20113761308133121310878
- LavoriniFManniniCChelliniEFontanaGAOptimising inhaled pharmacotherapy for elderly patients with chronic obstructive pulmonary disease: the importance of delivery devicesDrugs Aging201633746147327216613
- LexmondAJKruizingaTJHagedoornPRottierBLFrijlinkHWde BoerAHEffect of inhaler design variables on paediatric use of dry powder inhalersPLoS One201496e9930424901338
- van der PalenJKleinJJKerkhoffAHvan HerwaardenCLSeydelEREvaluation of the long-term effectiveness of three instruction modes for inhaling medicinesPatient Educ Couns1997321 SupplS87S959516764
- LeungJBhutaniMLeighRPelletierDGoodCSinDDEmpowering family physicians to impart proper inhaler teaching to patients with chronic obstructive pulmonary disease and asthmaCan Respir J201522526627026436910
- ChrystynHSmallMMilliganGHigginsVGilEGEstruchJImpact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPDRespir Med2014108235836524209768
- MolimardMColthorpePInhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitionersJ Aerosol Med Pulm Drug Deliv201528321922825265316
- AndersonPBenfordMHarrisNKaravaliMPiercyJReal-world physician and patient behaviour across countries: disease-specific programmes–a means to understandCurr Med Res Opin200824113063307218826746
- LavoriniFCorriganCJBarnesPJRetail sales of inhalation devices in European countries: so much for a global policyRespir Med201110571099110321489771
- RoggeriAMichelettoCRoggeriDPInhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issuesInt J Chron Obstruct Pulmon Dis20161159760227051283
- PascualSFeimerJDeSAPreference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre studyNPJ Prim Care Respir Med2015251501825927321
- van der PalenJGinkoTKrokerAPreference, satisfaction and errors with two dry powder inhalers in patients with COPDExpert Opin Drug Deliv20131081023103123745954
- van der PalenJvan der ValkPGoosensMGroothuis-OudshoornKBrusse-KeizerMA randomised cross-over trial investigating the ease of use and preference of two dry powder inhalers in patients with asthma or chronic obstructive pulmonary diseaseExpert Opin Drug Deliv20131091171117823815552
- HawkenNTorvinenSNeineMEPatient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experimentBMC Pulm Med20171719928683805
- JahediLDownieSRSainiBChanHKBosnic-AnticevichSInhaler technique in asthma: how does it relate to patients’ preferences and attitudes toward their inhalers?J Aerosol Med Pulm Drug Deliv2017301425227676193
- SvedsaterHDalePGarrillKWalkerRWoepseMWQualitative assessment of attributes and ease of use of the ELLIPTA dry powder inhaler for delivery of maintenance therapy for asthma and COPDBMC Pulm Med2013137224314123
- ChorãoPPereiraAMFonsecaJAInhaler devices in asthma and COPD–an assessment of inhaler technique and patient preferencesRespir Med2014108796897524873873
- RauJLDeterminants of patient adherence to an aerosol regimenRespir Care200550101346135616185370
- LevyMLDekhuijzenPNBarnesPJInhaler technique: facts and fantasies. a view from the Aerosol Drug Management Improvement Team (ADMIT)NPJ Prim Care Respir Med2016261601727098045
- NinaneVVandevoordeJCataldoDNew developments in inhaler devices within pharmaceutical companies: a systematic review of the impact on clinical outcomes and patient preferencesRespir Med2015109111430143826439177
- DekhuijzenPNLavoriniFUsmaniOSPatients’ perspectives and preferences in the choice of inhalers: the case for Respimat® or HandiHaler®Patient Prefer Adherence2016101561157227574405
- BattistiWPWagerEBaltzerLGood publication practice for communicating company-sponsored medical research: GPP3Ann Intern Med2015163646146426259067